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Abstract
Background: This study was designed to investigate an association between the methylenetetrahydrofolate reductase 
(MTHFR) C677T polymorphism and the risk of gastric and colorectal cancer in the Korean population.
Methods: We conducted a population-based large-scale case-control study involving 2,213 patients with newly 
diagnosed gastric cancer, 1,829 patients with newly diagnosed colorectal cancer, and 1,700 healthy controls. 
Genotyping was performed with peripheral blood DNA for MTHFR C677T polymorphisms. The statistical significance 
was estimated by logistic regression analysis.
Results: The MTHFR C677T frequencies of CC, CT, and TT genotypes were 35.2%, 47.5%, and 17.3% among stomach 
cancer, 34%, 50.5%, and 15.5% in colorectal cancer, and 31.8%, 50.7%, and 17.5% in the controls, respectively. The 
MTHFR 677TT genotype showed a weak opposite association with colorectal cancer compared to the homozygous CC 
genotype [adjusted age and sex odds ratio (OR) = 0.792, 95% confidence interval (CI) = 0.638-0.984, P = 0.035]. Subjects 
with the MTHFR 677CT showed a significantly reduced risk of gastric cancer compared whose with the 677CC 
genotype (age- and sex-adjusted OR = 0.810; 95% CI = 0.696-0.942, P = 0.006). We also observed no significant 
interactions between the MTHFR C677T polymorphism and smoking or drinking in the risk of gastric and colorectal 
cancer.
Conclusions: The T allele was found to provide a weak protective association with gastric cancer and colorectal cancer.
Background
Although gastric cancer incidence and mortality have
b e e n  d e c r e a s i n g  a r o u n d  t h e  w o r l d ,  i t  i s  s t i l l  t h e  m o s t
common cause of cancer death in Korea for both sexes
[1]. Colorectal cancer is very common and has increased
rapidly along with the westernization of lifestyle in Korea.
A l t h o u g h  H e l i c o b a c t e r  p y l o r i  ( H. pylori) strains have
been proposed to be a major cause of gastric cancer, they
do not provide a complete explanation. Epidemio- logical
studies have indicated an association between folate
intake and a reduced risk of certain cancers [2-5], includ-
ing gastric cancer [4] and colorectal cancer [3]. Folate
d e f i c i e n c i e s  m a y  r e s u l t  i n  a b n o r m a l  D N A  m e t h y l a t i o n
and uncontrolled gene expression leading to malignant
transformation [6,7].
Methylenetetrahydrofolate reductase (MTHFR) is an
enzyme that plays an essential role in the metabolism of
folic acid and catalyzes the irreversible reduction of 5,10-
methylenetetrahydrofolate to 5-methyltetrahydrofolate.
A change of C to T at nucleotide 677 in MTHFR C677T
results in an amino acid substance change of an alanine to
valine, and this substance is associated with reduced
enzyme activity that leads to reduced plasma folate levels
[8]. Low enzyme activity of MTHFR C677T variant geno-
types are associated with DNA hypomethylation, which
may induce genomic instability and thereby affect the
expression of oncogenes or tumor suppressor genes.
The association between the MTHFRC677T gene poly-
morphisms and genetic susceptibility to stomach cancer
and colorectal cancer has been widely evaluated in recent
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studies, but with controversial conclusions. Several stud-
ies reported that a homozygous variant genotype of the
polymorphism of MTHFRC677T was associated with an
increased risk of gastric cancer [9,10] and colorectal can-
cer [11,12]. However, other studies reported that individ-
uals with the MTHFR 677TT genotype had a decreased
risk of colorectal cancer[13], whereas yet others observed
no association between the MTHFRC677T genotype and
genetic susceptibility to gastric and colorectal cancer [14-
17]. Considering the studies provided to date, quite
inconsistent results have been reported on the associa-
tion of MTHFR C677T gene polymorphisms with genetic
susceptibility to stomach cancer and colorectal cancer.
We designed a large-scale population-based case-control
study in Korea to evaluate the potential role of the
MTHFR C677T gene polymorphism in gastric and col-
orectal cancer risk, which would help us to screen, treat,
survey, and prevent gastric and colorectal cancer.
Methods
Subjects
The study population consists of 2,213 patients with
newly diagnosed gastric cancer, 1,829 patients with newly
diagnosed colorectal cancer (colon cancer 833, rectal
cancer 996), and 1,700 population-based controls. All
enrolled patients were pathologically confirmed by
Chonnam National University Hwasun Hospital between
April 2004 and June 2008. Cases with secondary or recur-
rent tumors were excluded. The tumor stages were classi-
fied according to the TNM classification, including
clinical or pathological TNM stages. Gastric cancer was
classified by anatomical site as cardia (C16.0) or non-car-
dia (C16.1-16.8) and by histological types such as intesti-
nal, diffuse, or mixed type.
The control group(n = 1,700) consisted of participants
in the Thyroid Disease Prevalence Study [18], conducted
from July 2004 to January 2006 in Yeonggwang and Muan
Counties of Jeollanam-do Province and in Namwon City
of Jeollabuk-do, Korea. At the time of their peripheral
blood collections, all case and control subjects provided
their informed consent to participate in this study. This
study was approved by the Institutional Review Board of
the Chonnam National University Hwasun Hospital in
Hwasun, South Korea.
Genotyping
Genomic DNA was extracted from peripheral blood
using a QIAamp DNA Blood Mini Kit (Qiagen, Valencia,
CA, USA), according to the manufacturer's protocol.
Genotyping was performed by PCR-RFLP or real-time
PCR. The genotyping protocol for PCR-RFLP was
adapted from Frosst et al [19]. After HinfI (Takara,
Tokyo,Japan) restriction enzyme digestion, samples were
run on a 10% polyacrylamide gel (19:1) using Microtitre
Array Diagonal Gel Electrophoresis (MADGE; Madge-
Bio, Grantham and Southampton, UK).
Genotyping by real-time PCR was performed by allelic
discrimination, using dual-labeled probes containing
locked nucleic acids (LNA), in a real-time polymerase
chain reaction (PCR) assay. PCR primers and LNA
probes were designed and synthesized by Intergrated
DNA Technologies (IDT) (Coralville; City, IA, USA). PCR
primers producing a 104-bp amplicon were as follows:
forward primer, 5'-CTTTGAGGCTGACCTGAAGC-3'
and reverse primer, 5'-TCACAAAGCGGAA GAA
TGTG-3'. Dual-labeled LNA hybridization probes were
5'- FAM -ATG GcT ccc-BHQ1- 3' for the C allele and 5'-
cy5-cgA CTc cCg C-BHQ2-3' for the T allele (LNA bases
are denoted in upper case, single nucleotide polymor-
phisms are underlined). Real-time PCR was performed
using a Rotor-Gene 3000 multiplex system (Corbett
Research, Sydney, Australia) in a 10-μL reaction volume
containing 200 nM PCR primer, 10-10 nM each probe,
0.5 U f-taq polymerase (Solgent, Daejeon, Korea), and 40
ng of genomic.
Statistical analysis
The statistical significance of the differences between the
patient and control groups was estimated by logistic
regression analysis. Adjusted odds ratios (OR) were cal-
culated with logistic regression model that controlled for
sex and age and are given with 95% confidence intervals
(CI). Subjects with the wild type genotypes (MTHFR 677
CC) were considered to be baseline risk. The expected
frequency of control genotypes was checked by the
Hardy-Weinberg equilibrium test. Interactions of geno-
type with smoking, alcohol consumption, and age were
estimated using the logistic regression model, products of
scores for smoking habit (0, never and 1, ever), drinking
habit (0, non-drinker and 1, drinker), age (0, ≤ 65 years
and 1, >65 years) and genotype (0, CC genotype for refer-
ence allele; 1, CT genotype and 2, TT genotype). Sub-
group analysis was conducted on anatomical site,
histological type, and TNM staging. The subjects for
which there was missing data for smoking, drinking, ana-
tomical site, histological type, and TNM staging were
excluded in interaction and subgroup analysis related
with these variables. All analyses were performed using
the Statistical Package for the Social Sciences software
version 17.0 (SPSS, Chicago, IL, USA).
Results
The characteristics of the study population are presented
in Table 1. The mean age of patients with gastric cancer
and colorectal cancer was significantly higher compared
with the control group. A statistically significant sex dif-
ference was also found between patients with gastric and
colorectal cancer and healthy controls, and the controlCui et al. BMC Cancer 2010, 10:236
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group had more female subjects. The proportion of
smokers in gastric cancer cases was higher than that in
the controls, but the proportion among colorectal cancer
cases was lower than that in the controls. The proportion
of drinkers in both cancer groups was lower than that in
the controls.
Table 2 shows genotype distributions for MTHFR
C677T and their adjusted odds ratios and 95% confidence
intervals in gastric and colorectal cancer. The distribution
of the MTHFR C677T gene polymorphisms in the con-
trols was in Hardy-Weinberg equilibrium. The MTHFR
C677T frequencies of CC, CT, and TT genotypes were
Table 1: General characteristics of subjects
Characteristics Controls Gastric cancer Colorectal cancer
No 1700 2213 1829
Age, mean,years 52.2 ± 14.3 60.2 ± 12.1* 61.9 ± 11.4**
≤ 65 years 1321(77.7) 1314(59.4) 985(53.9)
>65 years 379(22.3) 899(40.6)* 844(46.1)**
Sex
Male 821(48.3) 1510(68.2) 1149(62.8)
Female 879(51.7) 703(31.8)* 680(37.2)**
Smoking habitat
Never 1000(58.8) 1127(50.9) 1137(62.2)
Ever 655(38.5) 997(45.1)* 582(31.8)**
missing 45(2.6) 89(4.0) 110(6.0)
Drinking habitat
Non-drinker 825(48.5) 1198(54.1) 1084(59.3)
Drinker 833(49.0) 921(41.6)* 623(34.1)**
Missing 42(2.5) 94(4.3) 122(6.7)
TNM Stage
I 1138(51.4) 291(15.9)
II 305(13.8) 547(29.9)
III 290(13.1) 615(33.6)
IV 386(17.4) 230(12.6)
Unspecified stage 94(4.2) 147(8.0)
Tumor site
Gastric cancer
Cardiac 106(4.8)
Non-cardiac 2093(94.6)
Unspecified site 14(0.6)
Colorectal cancer
Colon 833(45.5)
rectum 996(54.5)
Histological type
Intestinal 1286(58.1)
Diffuse 561(25.4)
Mixed 240(10.8)
Unspecified type 126(5.7)
The data is expressed as number, percent and mean ± standard deviation.
* Gastric cancer compared with control, p < 0.05;
**Colorectal cancer compared with control, p < 0.05.Cui et al. BMC Cancer 2010, 10:236
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35.2%, 47.5%, and 17.3% among gastric cancer, 34%,
50.5%, and 15.5% in colorectal cancer, and 31.8%, 50.7%,
and 17.5% in the controls, respectively. The frequencies
of the C and T allele were 59.0% and 41.0% among gastric
cancer, 59.2% and 40.8% in colorectal cancer, and 57.1%
and 42.9% in the controls, respectively. Compared with
the CC genotype, the TT genotype was significantly cor-
related with a reduced risk of colorectal cancer when
adjustments were made for age and sex (age- and sex-
adjusted OR = 0.792; 95% CI = 0.638-0.984, P = 0.035).
Although our results for MTHFR 677TT and gastric can-
cer risk did not reach statistical significance, the observed
trend (overall TT versus CC OR = 0.877; 95% CI = 0.719-
1.070) indicates a somewhat protective effect. Whereas
the 677CT genotype was significantly associated with a
reduced risk of gastric cancer, the age- and sex-adjusted
OR was 0.810 (95% CI = 0.696-0.942, P = 0.006).
Table 3 shows interaction between MTHFR C677T
polymorphisms and smoking and drinking habit and age
for gastric and colorectal cancer risk. When we used the
MTHFR 677CC genotype as the reference, smoking
habit, drinking habit, and age did not modify the associa-
tion between the MTHFR C677T genotypes and the risk
of gastric cancer or colorectal cancer. When results were
stratified by anatomical site, histological type, and TNM
staging, we observed no statistically significant differ-
ences in genotype distribution (Table 4).
Discussion
The current study represents the largest sample (2,213
gastric cancer, 1,829 colorectal cancer, and 1,700 con-
trols) of the Korean population ever used to evaluate the
possible association between the MTHFR C677T gene
polymorphisms and susceptibility to gastric and colorec-
tal cancer. The T allele was found to provide a weak pro-
tective association with gastric and colorectal cancer.
Previous reports on the MTHFR polymorphism and
their associations with stomach cancer have been quite
inconsistent. Of the published studies, some studies espe-
cially in China [20-22], Italy[9], and Mexico[10], found
that the MTHFR 677TT genotype was a strong risk factor
for gastric cancer, others no association[15-17], and only
one suggested a decreased risk[23]. Although our results
for MTHFR 677TT and gastric cancer risk did not reach
statistical significance, the observed trend (overall TT
versus CC OR = 0.877; 95% CI = 0.719-1.070) indicates a
somewhat protective effect, whereas the combination of
MTHFR 677CT revealed a significant protective associa-
tion with gastric cancer, the OR of overall CT versus CC
was 0.810 (95% CI, 0.696-0.942). In a Mexican popula-
tion, Galvan-Portillo et al. [23] reported a significant
reduction in diffuse gastric cancer risk for the MTHFR
677 TT genotype among individuals with high consump-
tion of folate (OR = 0.23; 95% CI 0.06-0.84) compared to
wild-type homozygous and heterozygous genotypes com-
bined. In fact, in other malignancies such as acute lym-
phocytic leukemia[24,25], breast cancer[26], and
colorectal cancer[27-29], studies have also reported a
protective association between the MTHFR 677TT geno-
type and the risk of some cancer. In addition, Jiang et al.
[30] also suggested that individuals with adequate folate
status who are homozygous for the MTHFR 677TT poly-
morphism have reduced the risk of colorectal cancer. Fur-
thermore, Chen, et al. [31] observed that the TT
genotype was protective in folate-replete subjects,
whereas the combination of TT and low folate status con-
ferred no protection, or even showed an increased risk.
These results suggest that the cancer risk associated with
MTHFR polymorphisms may exhibit a gene-nutrient
interaction that depends on the level of folate intake or
plasma folate levels. However, we could not evaluate the
gene-nutrient interaction in our study due to a lack of
d a t a  r e g a r d i n g  t h e  p l a s m a  f o l a t e  l e v e l s  o f  c a s e  g r o u p .
Although we had information on the plasma folate levels
of 1,700 healthy individuals in the control group, which
was based on the general population. The median level of
plasma folate was 22.7 nmol/L in our controls. Hao et al.
[ 3 2 ]  r e p o r t e d  t h a t  t h e  m e d i a n  v a l u e s  o f  p l a s m a  f o l a t e
were 16.7 nmol/L in South China and 8.4 nmol/L in
North China. This implies that Korean populations might
Table 2: MTHFR C677T genotype distributions and adjusted odds ratio for gastric and colorectal cancer
Gastric cancer Colorectal cancer
MTHFR C677T Controls Gastric cancer Colorectal cancer OR a (95% CI) P value OR a (95% CI) P value
CC 540(31.8) 778(35.2) 622(34.0) 1 1
CT 863(50.7) 1052(47.5) 923(50.5) 0.810(0.696-0.942) 0.006 0.923(0.787-1.082) 0.321
TT 297(17.5) 382(17.3) 284(15.5) 0.877(0.719-1.070) 0.195 0.792(0.638-0.984) 0.035
C 1943(57.1) 2608(59.0) 2167(59.2) 1 1
T 1457(42.9) 1816(41.0) 1491(40.8) 0.915(0.832-1.008) 0.071 0.902(0.814-0.999) 0.047
OR a, odds ratio adjusted for age and sex; CI, confidence interval;Cui et al. BMC Cancer 2010, 10:236
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have a relatively higher plasma folate level than do Chi-
nese people. It may be partially explained by the dietary
habits of Koreans. Rapid economic growth has led to
changes in Korean food consumption patterns: consump-
tion of the staple foods such as rice, barley and potatoes
has declined, whereas consumption of meat, fruit, vegeta-
bles and dairy products has increased. According to
Korean National Health and Nutrition Examination Sur-
vey report in 1998, 2001 and 2005, increasing trends in
daily vegetable consumption were shown in Korea[33]. It
has been known that vegetables and fruits are major
source of folate. In addition, the frequency of MTHFR TT
homozygotes was 17.5% in our 1,700 healthy controls,
which was consistent with findings for the control sub-
jects in Japan (17.2%)[34], but was lower than that
reported for control subjects in China (31.1-41%)[22,35].
Compared to Chinese people, the Korean population
might have a relatively low frequency of the MTHFR
677TT genotype and a relatively high plasma folate level.
This might provide a partial explanation why the MTHFR
677 mutations were found to be protective for gastric and
colorectal cancer in our study.
With regard to the MTHFR C677T genotype and the
risk of colorectal cancer, although it has been proposed
that the MTHFR polymorphism might be involved in the
etiology of cancer through regulation of DNA synthesis
and repair, some subsequent studies have not provided
evidence for their association with colorectal cancer. In a
Japanese case-control study of colorectal cancer[36,37],
results showed that the MTHFR C677T polymorphism
did not have a role in the development of colorectal can-
cer. In addition, Zeybek et al. [17] in Turkey, Plaschke et
al. [38] in Germany, and Derwinger et al. [14] in Sweden
also reported no association between the risk of colorec-
tal cancer and the MTHFR 677TT genotype. However,
several studies observed positive associations between
Table 3: Interaction between MTHFR C677T polymorphisms and smoking and drinking habit and age for gastric and 
colorectal cancer risk.
CT vs CC* TT vs CC* p for interactiona
ORa(95%CI) ORa(95%CI)
gastric cancer
Smoking habit
Never 0.874(0.693-1.102 0.984(0.722-1.339)
Ever 0.776(0.632-0.952) 0.825(0.630-1.079) 0.680
Drinking habit
Non-drinker 0.801(0.651-0.986) 0.853(0.647-1.124)
Drinker 0.827(0.656-1.042) 0.959(0.707-1.299) 0.847
Age
≤ 65 years 0.852(0.711-1.020) 0.921(0.726-1.167)
>65 years 0.700(0.529-0.925) 0.765(0.530-1.103) 0.581
colorectal cancer
Smoking habit
Never 0.993(0.762-1.293) 0.955(0.670-1.363)
Ever 0.851(0.688-1.053) 0.666(0.499-0.888) 0.301
Drinking habit
Non-drinker 0.854(0.689-1.059) 0.712(0.532-0.954)
Drinker 0.950(0.735-1.229) 0.878(0.620-1.243) 0.635
Age
≤ 65 years 0.966(0.819-1.211) 0.810(0.620-1.059)
>65 years 0.789(0.597-1.043) 0.759(0.525-1.099) 0.361
ORa ,adjusted for age and sex; CC*, CC as reference group
Interactiona was modeled as a product of smoking habit (0, never and 1, ever),
drinking habit (0,non-drinker and 1, drinker), age (0, ≤ 65 years and 1, >65 years) and genotype in score (0, CC genotype for reference allele; 
1, CT genotype and 2, TT genotype)Cui et al. BMC Cancer 2010, 10:236
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the MTHFR 677TT genotypes and increased risk for col-
orectal cancer. Miao et al. [39] in China and Guerreiro et
al[40]in Portugal demonstrated that the MTHFR 677TT
presented a increased risk of colorectal cancer. Our study
is consistent with a recent meta-analysis that concluded a
small but significant protective effect of MTHFR C677T
exists against colorectal cancer risk (overall TT versus CC
OR = 0.93; 95% CI, 0.89-0.98) for a worldwide population
[28].
Considering that heavy drinking and smoking are rec-
ognized as risk factors for gastric and colorectal cancer,
we included these factors in our study, our findings
showed no interactions between the MTHFR C677T
polymorphisms and drinking and smoking. With respect
to alcohol consumption and MTHFR genotypes, the
results were inconsistent. For colorectal risk, earlier stud-
ies reported that a protective effect of the MTHFR TT
genotype disappeared in those with a high alcohol intake
[27,29]. A recent Chinese study showed a 5-fold
increased gastric cancer risk in drinkers with the
MTHFR677T/T genotype[41], whereas a Japanese study
showed that the MTHFR 677TT genotype reduced
esophageal cancer risk among heavy-drinkers[42]. In
addition, no interactions were found between the
MTHFR C677T polymorphism and alcohol consumption
in the risk of gastric cancer [10,43]. Cigarette smoking
may decrease folate in plasma and produce a localized
deficiency of folic acid. Boccia et al. [44] observed that
ever smokers carrying the MTHFR 677 T allele showed a
significant increased risk of gastric cancer. Our results
showed no interaction between MTHFR C677T and
smoking in the risk of gastric and colorectal cancer. Yang
et al. [42] also did not observe any interaction between
the effect of the MTHFR C677T polymorphisms on
esophageal cancer risk and smoking.
To the best of our knowledge, only two studies have
examined the MTHFR polymorphisms and the risk of
gastric cancer and colorectal cancer in a Korean popula-
tion. However, those studies were based on limited sam-
ple sizes. One study by Kim et al. [15] involving 133
gastric cancer and 445 controls showed no relationship
between the MTHFR genotype and gastric cancer.
Another study included 243 colorectal cancer and 225
controls, results from this study showed no relationship
between the MTHFR C677T genotype and the overall
risk of colorectal cancer, but the T allele was found to be
a s s o c i a t e d  w i t h  a n  i n c r e a s e d  r i s k  o f  c o l o n  c a n c e r  a n d
with a somewhat decreased risk of rectal cancer[45]. Our
Table 4: Subgroup analysis by TNM stage, tumor site and histological type for the MTHFR C677T polymorphisms.
CT vs CC* TT vs CC*
ORa (95%CI) ORa (95%CI)
Gastric cancer
TNM stage
I+II 0.810(0.685-0.958) 0.933(0.750-1.161)
III+IV 0.844(0.685-1.040) 0.792(0.597-1.050)
Tumor site
Cardiac 0.906(0.569-1.442) 0.967(0.531-1.760)
Non-cardiac 0.811(0.696-0.944) 0.876(0.717-1.070)
Histological type
Intestinal 0.815(0.680-0.978) 0.865(0.681-1.099)
Diffuse 0.832(0.672-1.031) 0.868(0.654-1.153)
Mixed 0.827(0.600-1.139) 1.111(0.748-1.652)
Colorectal cancer
TNM stage
I+II 0.947(0.775-1.158) 0.854(0.652-1.119)
III+IV 0.823(0.679-0.997) 0.667(0.510-0.871)
Tumor site
Colon 0.942(0.744-1.146) 0.727(0.553-0.952)
Rectum 0.888(0.636-1.073) 0.855(0.666-1.099)
ORa, adjusted for age and sex; CC*, CC as reference groupCui et al. BMC Cancer 2010, 10:236
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result showed a tendency for lowered colorectal cancer
risk in individuals with the MTHFR 677TT genotype and
the same tendency was also found in colon and rectal
cancer.
The conflicting results regarding the associations
between MTHFR C677T polymorphisms and risks for
gastric cancer and colorectal cancer may be due to differ-
ent ethnicities, different subtypes, and differences in
regional dietary and local carcinogen exposures. In addi-
tion, many previous studies have considered relatively
small populations, leading to difficulties in assessing the
true statistical significance of the data.
The limitations of our study are that we did not deter-
mine serum folate levels or dietary folate intake in the
case groups, and we also did not collect the detailed data
on the risk factors of gastric cancer and colorectal cancer.
Therefore, we cannot add to the debate on the relation-
ship between gene-environment interactions.
Conclusions
The present case-control study in Korea found a protec-
tive effect of the MTHFR C677T variant genotype for
gastric and colorectal cancer and suggested that the
effects of the MTHFR C677T genotype may differ in pop-
ulations with different levels of folate intake.
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